REGN
Regeneron Pharmaceuticals Inc
798.20$
+1.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +44.9% | +24.3% | +25.7% | +33.9% | +26.2% | +15.9% | +48.2% | +14.9% | +13.2% | +14.1% | +7.4% | |
| – | +35.0% | +15.7% | +43.0% | +42.2% | -3.4% | +65.9% | +9.9% | +13.3% | +22.6% | -4.2% | -3.4% | |
| – | +24.7% | -33.9% | +51.9% | +80.6% | +10.2% | +35.6% | +31.5% | +7.6% | -12.1% | -8.9% | +25.3% | |
| – | +23.3% | -38.1% | +178.8% | +57.6% | -29.6% | +109.1% | -15.3% | +36.0% | +40.1% | -16.9% | -4.5% | |
| – | +44.3% | +9.8% | +22.5% | +13.6% | +24.2% | +47.7% | +46.7% | -11.7% | +6.4% | +9.6% | -7.6% | |
| – | +85.1% | +67.4% | +81.8% | +58.5% | +23.0% | +35.4% | +1.8% | +23.1% | +7.4% | +19.6% | +3.7% | |
| – | +63.6% | +30.7% | +13.2% | +9.2% | +12.2% | +11.5% | +8.1% | +8.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +13,564.2% | +13.4% | +10.6% | +9.5% | |
| – | +47.0% | +29.2% | +3.8% | +13.6% | +24.8% | +65.2% | +8.6% | -1.7% | +8.5% | +18.3% | +10.7% | |
| – | +22.7% | +63.2% | -22.1% | +39.8% | +55.1% | +33.9% | +40.1% | -20.1% | +9.0% | +15.2% | +10.8% | |
| – | +29.2% | -71.4% | +261.9% | -80.6% | – | – | -55.9% | +0.0% | – | – | – | |
| – | +41.7% | -4.2% | +32.0% | +22.5% | +91.6% | +13.7% | +18.6% | +4.5% | +3.0% | +30.2% | +18.9% | |
| – | +147.3% | -3.1% | +100.1% | – | – | – | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | +43.8% | +21.7% | +38.1% | +42.5% | +26.6% | -0.6% | +70.2% | +20.8% | +14.6% | +13.0% | +6.5% | |
| – | +233.9% | +105.0% | +68.6% | +78.3% | +40.5% | +47.6% | +74.1% | +22.9% | +17.0% | +16.2% | +13.0% | |
| – | +1.6% | +0.9% | -0.3% | -1.0% | -0.2% | +0.4% | -2.5% | +1.2% | +0.2% | +1.2% | -5.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.